Medicare Enrolled

Dr. Katherine Standley, DO

Neurology · Tampa, FL
3000 MEDICAL PARK DR STE 510, Tampa, FL 33613
8136157725
Registered in NPPES since 2009
NPI: 1154556181 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Standley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Standley? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Standley

Dr. Katherine Standley is a neurology specialist in Tampa, FL, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Standley received a total of $1,058,747 from 65 pharmaceutical and/or device companies across 2030 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Standley is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration $1,058,747 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$1,058,747
Total received (2018-2022)
Avg $211,749/year across 5 years
Top 1% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
2,030
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$97,013
2021
$249,707
2020
$132,938
2019
$252,876
2018
$326,213

Payments by company (2022)

Biohaven Pharmaceutical Holding Company Ltd.
$38,502
Amgen Inc.
$24,841
ABBVIE INC.
$17,365
Teva Pharmaceuticals USA, Inc.
$10,325
Biogen, Inc.
$3,626
IMPEL PHARMACEUTICALS INC.
$1,425
Celgene Corporation
$132
GENZYME CORPORATION
$128
Avanir Pharmaceuticals, Inc.
$88
Janssen Pharmaceuticals, Inc
$82
Novartis Pharmaceuticals Corporation
$68
Genentech USA, Inc.
$45
Lilly USA, LLC
$42
EMD Serono, Inc.
$34
Collegium Pharmaceutical, Inc.
$34
Banner Life Sciences, LLC
$34
Lundbeck LLC
$28
MDD US Operations, LLC
$24
Avion Pharmaceuticals
$23
Horizon Therapeutics plc
$22
Sunovion Pharmaceuticals Inc.
$21
Mallinckrodt Hospital Products Inc.
$21
Supernus Pharmaceuticals, Inc.
$21
Neurocrine Biosciences, Inc.
$19
Neurelis, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$16
Allergan, Inc.
$16
UPSHER-SMITH LABORATORIES LLC
$14
Top 3 companies account for 83.2% of 2022 payments
All-time payments by company (2018-2022) ›
Amgen Inc.
$339,601
GENZYME CORPORATION
$247,133
Biohaven Pharmaceuticals, Inc.
$124,142
Biogen, Inc.
$87,440
Genentech USA, Inc.
$59,339
Teva Pharmaceuticals USA, Inc.
$48,616
Biohaven Pharmaceutical Holding Company Ltd.
$38,502
Lilly USA, LLC
$35,153
Novartis Pharmaceuticals Corporation
$33,167
ABBVIE INC.
$17,365
Allergan, Inc.
$10,079
AbbVie Inc.
$6,857
Genentech, Inc.
$4,123
IMPEL PHARMACEUTICALS INC.
$1,425
Celgene Corporation
$1,203
EMD Serono, Inc.
$462
UCB, Inc.
$430
Allergan Inc.
$378
Supernus Pharmaceuticals, Inc.
$326
Sunovion Pharmaceuticals Inc.
$276
Avanir Pharmaceuticals, Inc.
$227
Janssen Pharmaceuticals, Inc
$182
GE HEALTHCARE
$171
E.R. Squibb & Sons, L.L.C.
$155
Alexion Pharmaceuticals, Inc.
$120
CSL Behring
$102
Lundbeck LLC
$100
Eisai Inc.
$90
Horizon Therapeutics plc
$81
Neurocrine Biosciences, Inc.
$78
ACADIA Pharmaceuticals Inc
$78
US WorldMeds, LLC
$73
Mallinckrodt Enterprises LLC
$72
SANOFI-AVENTIS U.S. LLC
$69
Mallinckrodt LLC
$67
Egalet US Inc
$64
Neurelis, Inc.
$63
ARBOR PHARMACEUTICALS, INC.
$60
Mallinckrodt Hospital Products Inc.
$60
SK Life Science, Inc.
$60
Amneal Pharmaceuticals LLC
$57
Upsher-Smith Laboratories LLC
$54
Grifols USA, LLC
$48
ASSERTIO THERAPEUTICS, Inc.
$45
Currax Pharmaceuticals LLC
$40
JAZZ PHARMACEUTICALS INC.
$37
Kyowa Kirin, Inc.
$37
Impax Laboratories, Inc.
$35
Bayer HealthCare Pharmaceuticals Inc.
$35
Collegium Pharmaceutical, Inc.
$34
Banner Life Sciences, LLC
$34
Bausch Health US, LLC
$33
Zyla Life Sciences
$31
Medtronic USA, Inc.
$30
UPSHER-SMITH LABORATORIES LLC
$29
BANNER LIFE SCIENCES, LLC
$24
MDD US Operations, LLC
$24
Avion Pharmaceuticals
$23
Jazz Pharmaceuticals Inc.
$19
Medtronic Vascular, Inc.
$17
Promius Pharma LLC
$17
Acorda Therapeutics, Inc
$17
Assertio Therapeutics, Inc.
$14
Zyla Life Sciences, Inc.
$13
Adamas Pharmaceuticals, Inc.
$12
Top 3 companies account for 67.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · CONTRAVE · COPAXONE · Cambia · DUOPA · ELYXYB - celecoxib · EMGALITY · Edarbi · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · Kcentra · LEMTRADA · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · OXTELLAR XR · Ongentys · PIPELINE-MS · Ponvory · QULIPTA · REYVOW · RYTARY · Rebif · Reveal LINQ · SOLIRIS · SPRIX · SUNOSI · SYNCHROMED · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · Vimpat · XCOPRI · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZINBRYTA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Tampa?
Compare neurologists in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
174
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH TAMPA
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2022
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Standley is a neurology specialist, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Standley receive payments from pharmaceutical companies?
Yes. Dr. Standley received a total of $1,058,747 from 65 companies across 2,030 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Standley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Tampa
Browse neurologists in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →